Abstract
Background. Although many children’s hospitals have established antimicrobial stewardship programs (ASPs), data-driven benchmarks for optimizing antimicrobial use across centers are lacking. We developed a multicenter quality improvement collaborative focused on sharing data reports and benchmarking antimicrobial use to improve antimicrobial prescribing among hospitalized children. Methods. A national antimicrobial stewardship collaborative among children’s hospitals, Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS), was established in 2013. Characteristics of the hospitals and their ASPs were obtained through a standardized survey. Antimicrobial-use data reports were developed on the basis of input from the participating hospitals. Collaborative learning opportunities were provided through monthly webinars and annual meetings. Results. Since 2013, 36 US hospitals have participated in the SHARPS collaborative. The median full-time equivalent (pharmacist and physician) dedicated to 30 of these ASPs was 0.75 (interquartile range, 0.45–1.4). To date, the collaborative has developed 26 data reports that include benchmarking reports according to specific antimicrobial agents, indications, and clinical service lines. The collaborative has conducted 27 webinars and 3 in-person meetings to highlight the stewardship work being conducted in the hospitals. The data reports and learning opportunities have resulted in approximately 36 distinct stewardship interventions. Conclusion. A pediatric antimicrobial stewardship collaborative has been successful in promoting the development of and innovation among pediatric ASPs. Additional research is needed to determine the impact of these efforts.
Original language | English (US) |
---|---|
Pages (from-to) | 124-128 |
Number of pages | 5 |
Journal | Journal of the Pediatric Infectious Diseases Society |
Volume | 7 |
Issue number | 2 |
DOIs | |
State | Published - May 15 2018 |
Funding
Financial support. This work was supported by a Pfizer Independent Grant for Learning & Change, and the Joint Commission provided administrative oversight. Pfizer and the Joint Commission had no role in the methods used to development or implement this collaborative. Potential conflicts of interest. J. G. N. is a consultant for RPS Diagnostics and has received grant funding from Merck. All other authors: No reported conflicts. All authors have submitted the ICMJE Form for Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Keywords
- Antibiotic
- Antimicrobial stewardship
- Quality improvement
ASJC Scopus subject areas
- General Medicine